Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Centrum Picks Top Pharma Stocks With 30% Expected Return



Centrum Equity Research has conducted a comprehensive analysis of the best pharma companies & picked those with 30% expected return




Centrum points out the Top 100 brands generated about 15% of the revenues and that the MNC pharma companies are the pioneers in brand building. It has a positive outlook for the pharma sector and has identified top picks for the pharma sector which are expected to give over 30% returns over CMP in one year.

Click here to download Centrum’s pharma stocks report
investments, Large Cap, Mid Cap, Multibagger, Portfolio, Top Picks    , ,

No Comments Yet

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 495 other subscribers

RSS Stocks Talk Forum

  • Suraj Estate Developers has a robust project lineup & launch pipeline. TP ₹992 (+73%)
    Suraj Estate Developers has a robust project lineup & launch pipeline, leadership position in redevelopment projects, strong cost advantage, proven track record, huge addressable market and healthy Balance Sheet with predictable cash flows. TP ₹992 (+73%) Download research report... Suraj Estate Developers has a robust project lineup & launch pipeline. TP ₹992 (+73%)
  • DCX Systems has the ability to become a key player in EMS space. TP ₹466 (+54%)
    DCX Systems has the ability to become a key player in EMS space with huge potential in railway & defence. It has ability to deliver high value complicated & critical products for leading defense players L&T & Lockheed. Order book ₹3000 Cr. TP ₹466 (+54%) Download... DCX Systems has the ability to become a key […]
  • Affle has a unique business model, unmatched network effects & prudent acquisition strategy
    Affle has a unique business model, unmatched network effects & prudent acquisition strategy. It is well-positioned to capitalize on growth in digital advertising in high-potential sectors such as e-commerce, fintech, gaming & entertainment. TP ₹2538 (60%) Download research report ... Affle has a unique business model, unmatched network effects & prudent acquisition strategy
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!